awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37458781-48DEA564-16DD-4922-B155-1F9F5D6FAA15
Q37458781-48DEA564-16DD-4922-B155-1F9F5D6FAA15
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37458781-48DEA564-16DD-4922-B155-1F9F5D6FAA15
Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology.
P2860
Q37458781-48DEA564-16DD-4922-B155-1F9F5D6FAA15
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37458781-48DEA564-16DD-4922-B155-1F9F5D6FAA15
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
304d7872571782783cad58687925e76a05b3eb10
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).